Analystreport

Karyopharm Therapeutics (KPTI) is now covered by Rodman & Renshaw. They set a "buy" rating on the stock.

Karyopharm Therapeutics Inc.  (KPTI) 
Last karyopharm therapeutics inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.karyopharm.com/investor-relations